leadf
logo-loader
viewMagicMed Industries Inc
(
CSE:MGIC
)

MagicMed Industries bring a fresh and unique approach to development of Psilocybin Derivatives

MagicMed Industries CEO Dr Joseph Tucker joined Steve Darling from Proactive Vancouver to talk about the company that intends to partner with pharmaceutical and other companies to develop psychedelic-derived medicinal and licit consumer goods products.

Tucker telling Proactive about their very experienced staff and also about their recent application for a U.S. patent.

Quick facts: MagicMed Industries Inc

Follow
CSE:MGIC

Price: - -

Market Cap: -

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

FOR OUR FULL DISCLAIMER CLICK HERE

Cipherpoint fully-focused on services and recurring revenue following...

Cipherpoint Ltd (ASX:CPT)'s Ted Pretty speaks to Proactive's Andrew Scott following the news it's sold its cp.protect and cp.discover technology assets to fellow ASX-lister archTIS Ltd. As part of the purchase agreement, archTIS is offering $1.4 million in cash for the Cipherpoint software...

17 hours, 22 minutes ago

2 min read